No you are wrong about filing an 8k because a company is hiring.
2. Phase II/III trials evaluate safety and efficacy. If efficacy is significant the FDA can fast track the review process and assign the therapy for Accerlerated Approval and commercialization. The FDA will evaluate MARVEL trial by comparing current standard of care. A company can market their therapy while going thru the confirmatory stage. RATD just changed the rules so FDA approval could be much faster than I've seen before.
Once the trial is complete, USRM will publish the abstract for FDA review.
3. Buyout offers are publicly disclosed in pacer filing.
4. The trial(s) are listed at clinical trials.gov
5. But you can also find links to all the DD here on the board.
Nothing posted here is improper or need disclosed publicly. An interested investor wanted to verify his DD. Who was also kind enough to share with the other investors. PERIOD
News 
Market Data 
Discover 
